Iovance Biotherapeutics, Inc. IOVA Intangible Amortization
Intangible Amortization at other companies
Other financials
Where this comes from
Reported directly by Iovance Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s intangible amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s intangible amortization?
- Iovance Biotherapeutics, Inc. (IOVA) reported intangible amortization of $5.72M in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s intangible amortization changed year-over-year?
- Iovance Biotherapeutics, Inc.'s intangible amortization increased by 4.0% year-over-year, from $5.5M to $5.72M.
- What does intangible amortization mean?
- Non-cash amortization of intangible assets (patents, customer relationships, technology) acquired through M&A or purchases.